Delaware Medical Marijuana Law

Operational

2011

Alzheimer’s disease
Amyotrophic Lateral Sclerosis
Anxiety**
Cachexia
Cancer
Chronic pain (that has not responded to previously prescribed medication or surgical measures for more than three months)
Cirrhosis
Epilepsy
Glaucoma
HIV/AIDS
Intractable epilepsy*
Migraine
Nausea
Post-traumatic Stress Disorder (PTSD)
Seizures
Severe and persistent muscle spasms (including those characteristic of multiple sclerosis)
++Any other debilitating condition, if the use is authorized by a physician and if “current standard care practices and treatments have been exhausted, and there are grounds to support that the patient may benefit from this treatment.”

*If the qualifying patient is younger than 18 years of age, the recommending physician must be a pediatric neurologist, pediatric gastroenterologist, pediatric oncologist or pediatric palliative care specialist. Adolescent patients are only permitted to possess oils containing at least 15 percent CBD (and no more than 7 percent THC) and/or oils containing 15 percent THC acid (and no more than 7 percent THC).

**Qualifying patients must possess a specific registry card identifying them as ‘CBD-rich’ patients. Varieties of cannabis which may be obtained by patients with this card are limited to those dominant in CBD and low in THC. (For more information, click here)